Enable breakthrough programs that
drive growth
Triple Ring offers a range of services and co-development arrangements to accelerate critical projects.
Fill key innovation gaps
Lorem Ipsum Dolor
We offer a range of flexible engagements to help you fill the 2-5 year innovation gap.
Lorem Ipsum Dolor 2
We provide market analysis, product ideation, regulatory strategy, technology landscaping, program design, incubation, and full product development to commercialization.
Lorem Ipsum Dolor 3
Our approaches include co-investment, shared risk models, non-dilutive funding assistance and IP licensing.
Corporate Venture Building
Expertise across science, engineering, and business to drive ventures
With over 100 technologists and experts in science, engineering, and commercialization, our multidisciplinary team offers deep domain expertise in areas like surgery, cardiology, neuro, and drug discovery.
We also bring venture-building experience, supported by in-house incubation facilities and cutting-edge labs.
Ready to discuss how we can help your corporate innovation efforts?
Partner with us to address challenges such as:
— Gaps between in-house innovation and M&A
— Time-to-market pressures
— The need for creative ways to fund innovation
— Difficulty developing products of increasing complexity
Bridge the gap between internal innovation & M&A
Triple Ring supports corporate venture building through its expertise in technology development, product design, and business strategy. This expertise has been built over two decades of developing breakthrough products and launching new businesses.
Speed to Market
Helping you accelerate innovation-driven growth at the challenging intersection of technology, biology, and medicine.
Expertise At The ready
End-to-end capabilities, from research and innovation, to design and development, to verification & validation.
Risk Sharing & Co-Development
Flexible engagement models, including venture building as a service or co-development partnerships.
FAQ
Corporate venture building is a strategy to drive innovation by developing new businesses from within large corporations or via external partnerships. Unlike traditional innovation models, corporate venture building integrates entrepreneurial methodologies with corporate resources, allowing companies to rapidly explore and scale new market opportunities without disrupting core operations.
In the rapidly evolving medtech and life-science landscapes, staying competitive requires constant innovation. Yet, balancing core operations with the pursuit of breakthrough technologies can be challenging. Triple Ring offers corporate venture building solutions that allow your company to explore, develop, and scale new opportunities without disrupting existing operations. With two decades of experience and a track record of successful product development, we help your team advance innovation through flexible, venture building engagement models.
Triple Ring supports corporate venture building through its expertise in business strategy, technology development, and product design. Partnering with us means having access to unparalleled expertise in both clinical applications and engineering, ensuring your projects are not only scientifically sound but also market ready. We bring together academic-level intellect with a focused drive to deliver high-quality products.
We offer a range of co-development partnership models, including:
—Skin-in-the-game” product development – Co-development programs including shared-risk contract development and royalty-based IP creation
—Spin-outs and spin-ins – Build-to-buy startup structures with third-party investment and carve-outs to create value from non-core technology
—Non-dilutive funding collaborations – Partnerships to attract funding from agencies including ARPA-H, BARDA, and NIH
We have a deep understanding of the full innovation cycle from concept to market launch. Our proven track record of success accelerating innovation has been created over our 20-year history and 500+ projects. Our staff collectively holds over 300 patents, and we generate new IP for clients routinely. We have earned high satisfaction and retention rates across our client community which includes many of the world’s largest medtech and life science companies, and the brightest startups throughout the world’s healthcare innovation hubs.
It is possible. Together.
Developing new technology is inherently difficult and risky. As a co-development company, we strive to be a trusted partner, not simply a consultant. We structure projects to meet the business needs of our clients, and we often share risk.